StockWatch
·
HomeLiveWeekly

BAL PHARMA LTD.

BSE: 524824

OverviewP/LShare Hold
values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-12.7525.0262.80100.57Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026

Margin Trend

percentage
OPM %NPM %
-12.88-3.266.3715.99Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
PeriodQ4 FY2026Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025
INCOME
Revenue83.92-4.1%87.49+18.6%73.75+12.4%65.64-19.7%81.78+12.2%72.89-2.4%74.70
Other Income-0.22-163.2%0.35-69.6%1.13+53.1%0.74-25.2%0.99+20.9%0.82+137.7%0.34
Total Income83.70-4.7%87.84+17.3%74.88+12.8%66.38-19.8%82.77+12.3%73.70-1.8%75.05
EXPENSES
Expenditure80.39-6.4%85.89+15.9%74.10+12.2%66.05-17.4%79.96+10.3%72.50-1.4%73.52
Tax-0.390.000.000.00+100.0%-2.79-5919.0%0.05-85.0%0.32
PROFIT
PBT3.31+70.3%1.95+149.0%0.78+141.7%0.32-88.5%2.81+133.7%1.20-20.9%1.52
Net Profit3.70+90.1%1.95+149.0%0.78+141.7%0.32-94.2%5.61+385.0%1.16-3.9%1.20
KEY METRICS
OPM %12.66%+1.60pp11.06%+3.23pp7.83%-1.54pp9.37%-0.21pp9.58%+19.13pp-9.55%-2.69pp-6.86%
NPM %4.42%+2.20pp2.22%+1.18pp1.04%+0.55pp0.49%-6.28pp6.77%+5.20pp1.57%-0.03pp1.60%
EPS2.60+113.1%1.22+149.0%0.49+145.0%0.20-94.3%3.51+380.8%0.73-3.9%0.76

Corporate Events

Board MeetingBALPHARMA
2026
27May

Board Meeting

The board meeting is scheduled to consider and approve the a…

BSE Filing ↗
Board MeetingBALPHARMA
2025
13Feb

Board Meeting

Regular agenda items

BSE Filing ↗
Board MeetingBALPHARMA
2024
14Nov

Board Meeting

To take on record and approve the Un-audited standalone and …

BSE Filing ↗
Board MeetingBALPHARMA
2024
9Sep

Board Meeting

Allotment Of Equity Shares To The Employees Of The Company U…

BSE Filing ↗
Board MeetingBALPHARMA
2024
28May

Board Meeting

Approval of Audited Standalone and Consolidated financial re…

BSE Filing ↗
Board MeetingBALPHARMA
2024
12Feb

Board Meeting

Approval of Un-audited Standalone and Consolidated financial…

BSE Filing ↗
Board MeetingBALPHARMA
2023
8Nov

Board Meeting

Approval of Un-audited Standalone and Consolidated financial…

BSE Filing ↗
DividendBALPHARMA
2023
25Sep

₹0.01 / share

BSE Filing ↗
Board MeetingBALPHARMA
2023
11Aug

Board Meeting

Consideration and approval of Un-Audited Standalone and Cons…

BSE Filing ↗